We had the opportunity to talk to the principal investigator of the TITAN
trial, Prof. Dr. K. Chi after he presented the final analysis of this study
during the virtual ASCO-GU congress.[1]
In this video Prof. Dr. Chi shares his clinical experience with Erleada
(apalutamide) and explains the TITAN study design, patient population,
key efficacy and safety results.[1]
The titration phase of Uptravi can prove challenging for the patient. This video was developed to support the patient during this process and can be used together with the patient titration guide.
